Expression levels of TFEB (GSE1007_GPL92_50221_at) and its target genes (SQSTM1, MAP1LC3B, or BECN1) were decreased in DMD patients (Fig. 2a and e), although LAMP1, ATP6V1a and MCOLN1, were not reduced in DMD (Fig. 2e). This evidence concerns the gene ATP6V1A and Duchenne muscular dystrophy.